ANGELA STUFF: Open Payments
NPI 1700319605 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 10 payments from 7 companies in 2025. Trend: 2023 $10,786 · 2024 $9,016 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $363 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Braeburn Inc. | 1 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $96 |
| ABBVIE INC. | 2 | $47 |
| Lilly USA, LLC | 1 | $33 |
Products named: ABILIFY MAINTENA, Auvelity, COBENFY, REXULTI, BRIXADI, CAPLYTA, VRAYLAR, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
